Literature DB >> 2706856

Posteromedial release for idiopathic talipes equinovarus. A long-term follow-up study.

M N Levin1, K N Kuo, G F Harris, D V Matesi.   

Abstract

Eighteen children with 26 idiopathic talipes equinovarus deformities were treated by postermedial release (PR) in the interval between 1975 and 1980 and investigated retrospectively. Evaluations included physical examination, functional evaluation, roentgenographic evaluation, and evaluation of foot track tracing pattern. The average follow-up period was 8.2 years. Thirty percent had had previous tendo Achilles lengthenings and 15% had had previous lengthenings plus posterior capsulotomies. Based on Turco's criteria, the results of PR were graded 38.9% excellent, 26.9% good, 15.6% fair, and 18.6% failure.

Entities:  

Mesh:

Year:  1989        PMID: 2706856

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Leg length discrepancy in unilateral congenital clubfoot following surgical treatment.

Authors:  Kenneth J Noonan; Alex M Meyers; Kosmas Kayes
Journal:  Iowa Orthop J       Date:  2004

2.  The impact of different types of talus deformation after treatment of clubfeet.

Authors:  Alexander Kolb; Madeleine Willegger; Reinhard Schuh; Alexandra Kaider; Catharina Chiari; Reinhard Windhager
Journal:  Int Orthop       Date:  2016-10-11       Impact factor: 3.075

3.  Long-term results of comprehensive clubfoot release versus the Ponseti method: which is better?

Authors:  Peter A Smith; Ken N Kuo; Adam N Graf; Joseph Krzak; Ann Flanagan; Sahar Hassani; Angela K Caudill; Fredrick R Dietz; Jose Morcuende; Gerald F Harris
Journal:  Clin Orthop Relat Res       Date:  2013-11-19       Impact factor: 4.176

4.  Mid-term results of a physiotherapist-led Ponseti service for the management of non-idiopathic and idiopathic clubfoot.

Authors:  Mia Dunkley; Yael Gelfer; Debbie Jackson; Evette Parnell; Jennifer Armstong; Cristina Rafter; Deborah M Eastwood
Journal:  J Child Orthop       Date:  2015-06-14       Impact factor: 1.548

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.